Obesity Rate Increasing in U.S. Adults With Type 1 Diabetes

MONDAY, Jan. 31, 2022 (HealthDay News) -- The prevalence of obesity is increasing among individuals with type 1 diabetes (T1D), and it is associated with an elevated risk for chronic kidney disease, according to a study published online Jan. 26 in the Journal of Clinical Endocrinology & Metabolism.
Amelia S. Wallace, from the Johns Hopkins Bloomberg School of Public Health in Baltimore, and colleagues examined the link between obesity and chronic kidney disease among individuals with T1D compared to those with type 2 diabetes (T2D) in the Geisinger Health System from 2004 to 2018. Trends were assessed in obesity (body mass index, ≥30 kg/m2), low estimated glomerular filtration rate (eGFR; ≤60 mL/min/1.73 m2), and albuminuria (urine albumin-to-creatinine ratio, ≥30 mg/g).
The researchers observed an increase in obesity in T1D from 2004 to 2018 (32.6 to 36.8 percent), while obesity was stable in T2D, at about 60 percent. In all years, the crude prevalence of low eGFR was higher in T2D than T1D (e.g., in 2018: 30.6 versus 16.1 percent); after adjustment for age differences, a higher prevalence was seen in T1D than T2D in all years (e.g., in 2018: 16.2 versus 9.3 percent). In T1D and T2D, obesity was associated with increased odds of low eGFR (adjusted odds ratios, 1.52 and 1.29, respectively).
"Kidney disease is often considered more common in people with type 2 diabetes, but our data shows adults with type 1 diabetes actually had a higher risk of kidney disease than those with type 2," a coauthor said in a statement.
Abstract/Full Text (subscription or payment may be required)
Related Posts
¿Los complementos de aceite de pescado de verdad mejoran la salud?
JUEVES, 24 de agosto de 2023 (HealthDay News) -- Si pasa frente a cualquier...
Breast Cancer Genetic Test
You may have heard that some genes put women at extra risk for breast cancer. If...
Fast-Food Consumption Linked to Liver Steatosis
WEDNESDAY, Jan. 18, 2023 (HealthDay News) -- Fast-food consumption is associated...
Updated Booster Shots, Not Original COVID Vaccines, Should Be Standard: FDA Panel
THURSDAY, Jan. 26, 2023 (HealthDay News) -- The U.S. Food and Drug...